{"id":24,"date":"2025-02-12T15:12:51","date_gmt":"2025-02-12T15:12:51","guid":{"rendered":"http:\/\/www.vampire-eu.com\/offerings\/"},"modified":"2026-02-10T16:54:19","modified_gmt":"2026-02-10T16:54:19","slug":"consortium","status":"publish","type":"page","link":"https:\/\/www.vampire-eu.com\/fr\/consortium\/","title":{"rendered":"Consortium"},"content":{"rendered":"
\n

Unir nos forces pour la d\u00e9tection pr\u00e9coce de la maladie de Parkinson<\/h1><\/div><\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n

Rencontrez les participants<\/h2><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Linkcare Health Services SL<\/h3><\/div><\/div>

Depuis 2020, LINKCARE BIOSCREENING\u2122 de Linkcare est l\u2019unit\u00e9 biotechnologique de Linkcare Health Services d\u00e9di\u00e9e \u00e0 la conception de dispositifs de diagnostic in vitro de point de service pour le d\u00e9pistage des maladies o\u00f9 la d\u00e9tection pr\u00e9coce constitue une avanc\u00e9e majeure dans le pronostic.
Les axes de recherche actuels portent sur la d\u00e9tection pr\u00e9coce du cancer et des maladies neurod\u00e9g\u00e9n\u00e9ratives.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Casa di Cura IGEA<\/h3><\/div><\/div>

IGEA est un h\u00f4pital qui accueille des patients pour un programme de r\u00e9\u00e9ducation intensive li\u00e9 \u00e0 diff\u00e9rents troubles (par exemple, pathologies neurod\u00e9g\u00e9n\u00e9ratives, l\u00e9sions vasculaires c\u00e9r\u00e9brales centrales). En particulier, le \u00ab D\u00e9partement des sciences de la neuro-r\u00e9\u00e9ducation \u00bb est structur\u00e9 comme une unit\u00e9 de r\u00e9\u00e9ducation op\u00e9rationnelle comprenant 148 lits, affili\u00e9e au syst\u00e8me national italien de sant\u00e9, et englobe les activit\u00e9s de r\u00e9\u00e9ducation intensive suivies par les patients hospitalis\u00e9s pour r\u00e9cup\u00e9rer de handicaps neurologiques importants.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Asociaci\u00f3n Parkinson Madrid<\/h3><\/div><\/div>

APM est une organisation \u00e0 but non lucratif dont la mission principale est de fournir soins et attention aux personnes diagnostiqu\u00e9es avec la maladie de Parkinson et \u00e0 leurs familles. Elle a \u00e9t\u00e9 cr\u00e9\u00e9e en 1994 et reconnue d\u2019int\u00e9r\u00eat public en 2001. L\u2019Asociaci\u00f3n Parkinson Madrid compte actuellement 1 800 membres, 130 b\u00e9n\u00e9voles et 55 salari\u00e9s, ce qui en fait la plus grande association offrant des services sociaux et de soins au niveau national.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Universitaetsmedizin Goettingen<\/h3><\/div><\/div>

Gr\u00e2ce aux fonds obtenus par une subvention de planification r\u00e9ussie de l'\u00c9tat de Basse-Saxe et \u00e0 des financements tiers acquis, nous menons des recherches de haut niveau et comptons parmi les plus grandes facult\u00e9s de m\u00e9decine en Allemagne en termes de nombre de candidats aux places d\u2019\u00e9tudes.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Fondazione European Brain Research Institute Rita Levi-Montalcini<\/h3><\/div><\/div>

Fond\u00e9 en 2002 par la laur\u00e9ate du prix Nobel Rita Levi-Montalcini, l\u2019Institut europ\u00e9en de recherche sur le cerveau est un centre de recherche \u00e0 but non lucratif d\u00e9di\u00e9 \u00e0 la compr\u00e9hension des fonctions c\u00e9r\u00e9brales sup\u00e9rieures et \u00e0 l\u2019\u00e9tude du cerveau \u00e0 diff\u00e9rents niveaux, des mol\u00e9cules, synapses, cellules nerveuses et gliales, circuits neuronaux jusqu\u2019au comportement.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Almawave SPA<\/h3><\/div><\/div>

Notre objectif est de concr\u00e9tiser le processus de transformation num\u00e9rique dans la vie quotidienne. Nous am\u00e9liorons les connaissances et rationalisons les services, en exploitant le potentiel de l\u2019intelligence artificielle dans des contextes complexes.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

SYNLAB Italia S.R.L.<\/h3><\/div><\/div>

SYNLAB Italie fait partie du groupe SYNLAB, principal fournisseur paneurop\u00e9en de services de laboratoire clinique et de diagnostic m\u00e9dical, offrant une large gamme de plus de 5 000 types de tests dans toutes les disciplines diagnostiques, y compris les tests g\u00e9n\u00e9tiques, la pathologie anatomique et l\u2019imagerie diagnostique. SYNLAB r\u00e9alise plus de 500 millions de tests par an et prend en charge plus de 100 millions de patients chaque ann\u00e9e. Le laboratoire central en Italie (Castenedolo, Brescia) est accr\u00e9dit\u00e9 UNI EN ISO 15189. SYNLAB est \u00e9galement actif dans la recherche biom\u00e9dicale, g\u00e9rant des collaborations actives avec les NHS Foundation Trusts Guy\u2019s and St Thomas\u2019 et King\u2019s College Hospital \u00e0 Londres ainsi qu\u2019avec l\u2019IRCCS SYNLAB SDN \u00e0 Naples.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Universitat Aut\u00f2noma de Barcelona<\/h3><\/div><\/div>

L\u2019Universit\u00e9 Autonome de Barcelone (UAB), situ\u00e9e \u00e0 Bellaterra pr\u00e8s de Barcelone, est une universit\u00e9 publique de premier plan en Espagne. Fond\u00e9e en 1968, elle est reconnue pour son excellence en enseignement, recherche et attractivit\u00e9 internationale des talents. Dans le classement mondial QS 2025, l\u2019UAB se classe 3e en Espagne, 175e au niveau mondial et 74e en Europe.
Fond\u00e9 en 1970, l\u2019Institut de biotechnologie et biom\u00e9decine (IBB) fait progresser la recherche cliniquement pertinente pour am\u00e9liorer le diagnostic et le traitement du cancer, des maladies neurod\u00e9g\u00e9n\u00e9ratives et immunitaires. Il comprend 18 groupes de recherche r\u00e9partis en trois programmes : Prot\u00e9omique appliqu\u00e9e et ing\u00e9nierie des prot\u00e9ines, G\u00e9nomique de l\u2019\u00e9volution et des maladies, et M\u00e9canismes de r\u00e9ponse au stress et aux maladies.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Spitalul Universitar De Urgenta Bucuresti<\/h3><\/div><\/div>

Reconnu comme l\u2019un des plus grands \u00e9tablissements m\u00e9dicaux d\u2019urgence en Roumanie, dot\u00e9 d\u2019un service de neurologie \u00e9quip\u00e9 de 120 lits. Ce service est d\u00e9di\u00e9 aux soins des patients souffrant d\u2019un large \u00e9ventail de pathologies neurologiques, incluant mais sans s\u2019y limiter aux accidents vasculaires c\u00e9r\u00e9braux, scl\u00e9rose en plaques, maladie de Parkinson, SLA, troubles neuro-immunologiques et \u00e9pilepsie r\u00e9sistante aux traitements.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Aristotelio Panepistimio Thessalonikis<\/h3><\/div><\/div>

Le d\u00e9partement de neurologie de l\u2019h\u00f4pital Papanikolaou propose plusieurs programmes ax\u00e9s sur la lutte contre la neurod\u00e9g\u00e9n\u00e9rescence et la facilitation de la r\u00e9paration neuronale, tant sur le plan clinique que de la recherche. La mission du d\u00e9partement est de transformer la science de pointe en nouvelles th\u00e9rapies et diagnostics qui b\u00e9n\u00e9ficient directement aux personnes atteintes de maladies neurod\u00e9g\u00e9n\u00e9ratives.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Institut National De La Sant\u00e9 Et De La Recherche Medicale<\/h3><\/div><\/div>

Fond\u00e9 en 1964, l\u2019Inserm est un institut public scientifique et technologique plac\u00e9 sous la double tutelle des minist\u00e8res fran\u00e7ais de la Sant\u00e9 et de la Recherche. L\u2019institut est d\u00e9di\u00e9 \u00e0 la recherche biom\u00e9dicale et \u00e0 la sant\u00e9 humaine, et intervient sur toute la cha\u00eene d\u2019activit\u00e9s, du laboratoire au chevet du patient. Il collabore \u00e9galement avec les institutions de recherche les plus prestigieuses au monde, engag\u00e9es dans les d\u00e9fis scientifiques et les progr\u00e8s dans ces domaines.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Instytut Psychiatrii I Neurologii<\/h3><\/div><\/div>

L\u2019Institut de psychiatrie et neurologie a \u00e9t\u00e9 fond\u00e9 en 1951 \u00e0 Varsovie. Il est aujourd\u2019hui un centre scientifique de premier plan en Pologne, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement de nouvelles m\u00e9thodes pour le traitement et la r\u00e9\u00e9ducation des troubles psychiatriques et neurologiques. Il dispose d\u2019installations diagnostiques et cliniques modernes permettant le diagnostic et le traitement des maladies neurologiques et psychiatriques. Il intervient en milieu hospitalier et r\u00e9alise \u00e9galement des consultations en ambulatoire.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

LEITAT <\/h3><\/div><\/div>

Leitat est un centre de recherche priv\u00e9 fort de plus de 110 ans d'exp\u00e9rience dans les processus d'innovation industrielle et une r\u00e9f\u00e9rence aux niveaux national et europ\u00e9en. Leitat a pour ambition de transformer les r\u00e9sultats technologiques et scientifiques en valeur \u00e9conomique et comp\u00e9titive pour ses clients et partenaires. Il contribue \u00e9galement au d\u00e9veloppement des connaissances et de l'innovation par la recherche appliqu\u00e9e et les essais techniques dans les domaines de la chimie, de l'\u00e9nergie, de l'environnement, des mat\u00e9riaux, de l'ing\u00e9nierie et des sciences de la vie. Avec une \u00e9quipe de plus de 400 professionnels, Leitat propose des solutions flexibles pour relever tous les d\u00e9fis industriels.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Universidad de Oviedo<\/h3><\/div><\/div>

L\u2019Universit\u00e9 d\u2019Oviedo est l\u2019institution publique d\u2019enseignement sup\u00e9rieur et de recherche du Principaut\u00e9 des Asturies. Forte de plus de 410 ans d\u2019histoire, elle propose un large \u00e9ventail de dipl\u00f4mes adapt\u00e9s \u00e0 l\u2019Espace europ\u00e9en de l\u2019enseignement sup\u00e9rieur (EEES) dans toutes les branches du savoir, des parcours bilingues, des doubles dipl\u00f4mes avec des universit\u00e9s internationales, ainsi que des masters Erasmus Mundus et interuniversitaires, en collaboration avec plus de 250 entreprises.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Sapienza University of Rome<\/h3><\/div><\/div>

Le D\u00e9partement de neurosciences humaines de l'Universit\u00e9 Sapienza de Rome int\u00e8gre la recherche fondamentale et clinique en neurologie, psychiatrie, neurochirurgie et psychologie. Fort d'une tradition remontant \u00e0 1883, il est dirig\u00e9 depuis 2021 par le Professeur Giovanni Fabbrini. Il est reconnu pour des contributions majeures telles que l'\u00e9lectroconvulsivoth\u00e9rapie. Ces derni\u00e8res d\u00e9cennies, il a poursuivi son d\u00e9veloppement gr\u00e2ce \u00e0 des collaborations nationales et internationales, des publications \u00e0 fort impact et des \u00e9v\u00e9nements scientifiques, conservant ainsi un r\u00f4le de premier plan en neurosciences et en soins cliniques.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div><\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

University of Newcastle <\/h3><\/div><\/div>

L\u2019Universit\u00e9 de Newcastle est reconnue pour son excellence en m\u00e9decine translationnelle, innovation clinique et \u00e9quit\u00e9 en sant\u00e9. Elle exploite ces comp\u00e9tences dans de nombreux domaines, notamment les neurosciences, le cancer, l\u2019inflammation et la sant\u00e9 des populations autochtones, pour faire progresser la m\u00e9decine. Son programme de formation est reconnu mondialement pour former des professionnels de sant\u00e9 hautement qualifi\u00e9s et ax\u00e9s sur la recherche. En tant que partenaire hors UE, elle apporte son expertise et sa propri\u00e9t\u00e9 intellectuelle pour des m\u00e9thodologies innovantes de biopsie liquide utilis\u00e9es dans l\u2019isolement des NDEVs pour le diagnostic des troubles c\u00e9r\u00e9braux.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n

Ce projet a re\u00e7u un financement dans le cadre du programme HORIZON-HLTH-2024-DISEASE-03 \u00e0 deux \u00e9tapes de l\u2019Union europ\u00e9enne. grant agreement No 101156370<\/a>.
Les points de vue et opinions exprim\u00e9s sont toutefois ceux de l\u2019auteur ou des auteurs uniquement et ne refl\u00e8tent pas n\u00e9cessairement ceux de l\u2019Union europ\u00e9enne ou de HORIZON-RIA. Ni l\u2019Union europ\u00e9enne ni l\u2019autorit\u00e9 de financement ne peuvent \u00eatre tenues responsables.<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

Rencontrez les participants<\/p>","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"no-sidebar","site-content-layout":"","ast-site-content-layout":"full-width-container","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"enabled","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-24","page","type-page","status-publish","hentry"],"yoast_head":"\nConsortium - V\u03b1MPiRE<\/title>\n<meta name=\"description\" content=\"Parkinson's disease early detection\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vampire-eu.com\/fr\/consortium\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Consortium - V\u03b1MPiRE\" \/>\n<meta name=\"twitter:description\" content=\"Parkinson's disease early detection\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vampire-eu.com\/consortium\/\",\"url\":\"https:\/\/www.vampire-eu.com\/consortium\/\",\"name\":\"Consortium - V\u03b1MPiRE\",\"isPartOf\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vampire-eu.com\/consortium\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vampire-eu.com\/consortium\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg\",\"datePublished\":\"2025-02-12T15:12:51+00:00\",\"dateModified\":\"2026-02-10T16:54:19+00:00\",\"description\":\"Parkinson's disease early detection\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vampire-eu.com\/consortium\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vampire-eu.com\/consortium\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.vampire-eu.com\/consortium\/#primaryimage\",\"url\":\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg\",\"contentUrl\":\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vampire-eu.com\/consortium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vampire-eu.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consortium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vampire-eu.com\/#website\",\"url\":\"https:\/\/www.vampire-eu.com\/\",\"name\":\"V\u03b1MPiRE\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vampire-eu.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vampire-eu.com\/#organization\",\"name\":\"V\u03b1MPiRE\",\"url\":\"https:\/\/www.vampire-eu.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png\",\"contentUrl\":\"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png\",\"width\":512,\"height\":512,\"caption\":\"V\u03b1MPiRE\"},\"image\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/showcase\/biosomics\/about\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consortium - V\u03b1MPiRE","description":"Parkinson's disease early detection","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vampire-eu.com\/fr\/consortium\/","twitter_card":"summary_large_image","twitter_title":"Consortium - V\u03b1MPiRE","twitter_description":"Parkinson's disease early detection","twitter_image":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vampire-eu.com\/consortium\/","url":"https:\/\/www.vampire-eu.com\/consortium\/","name":"Consortium - V\u03b1MPiRE","isPartOf":{"@id":"https:\/\/www.vampire-eu.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vampire-eu.com\/consortium\/#primaryimage"},"image":{"@id":"https:\/\/www.vampire-eu.com\/consortium\/#primaryimage"},"thumbnailUrl":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg","datePublished":"2025-02-12T15:12:51+00:00","dateModified":"2026-02-10T16:54:19+00:00","description":"Parkinson's disease early detection","breadcrumb":{"@id":"https:\/\/www.vampire-eu.com\/consortium\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vampire-eu.com\/consortium\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.vampire-eu.com\/consortium\/#primaryimage","url":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg","contentUrl":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/LinkcareBioscreening-300x91.jpeg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.vampire-eu.com\/consortium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vampire-eu.com\/"},{"@type":"ListItem","position":2,"name":"Consortium"}]},{"@type":"WebSite","@id":"https:\/\/www.vampire-eu.com\/#website","url":"https:\/\/www.vampire-eu.com\/","name":"V\u03b1MPiRE","description":"","publisher":{"@id":"https:\/\/www.vampire-eu.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vampire-eu.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.vampire-eu.com\/#organization","name":"V\u03b1MPiRE","url":"https:\/\/www.vampire-eu.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png","contentUrl":"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png","width":512,"height":512,"caption":"V\u03b1MPiRE"},"image":{"@id":"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/showcase\/biosomics\/about"]}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"Pedro Sanchez","author_link":"https:\/\/www.vampire-eu.com\/fr\/author\/slpedro\/"},"uagb_comment_info":0,"uagb_excerpt":"Meet the participants","_links":{"self":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages\/24","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/comments?post=24"}],"version-history":[{"count":165,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages\/24\/revisions"}],"predecessor-version":[{"id":5591,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages\/24\/revisions\/5591"}],"wp:attachment":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/media?parent=24"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}